Back |
home / stock / rpd / rpd message board
Subject | By | Source | When |
---|---|---|---|
Nice man, hope you do very well there! GL! | PennyStockPickz | investorshub | 08/17/2015 11:31:31 PM |
Thanks a lot. i dont trade a lot.. | mirza3 | investorshub | 08/17/2015 11:30:57 PM |
Sounds good brotha! Wish you the best as | PennyStockPickz | investorshub | 08/17/2015 11:25:23 PM |
wish you best..im already in another one...for long.. | mirza3 | investorshub | 08/17/2015 11:19:07 PM |
Earnings tomorrow could send this on an epic | PennyStockPickz | investorshub | 08/17/2015 11:06:17 PM |
good luck.. | mirza3 | investorshub | 08/17/2015 11:03:20 PM |
I added some shares this morning. Not buying | iDoubt | investorshub | 08/06/2015 2:34:48 AM |
Yes insiders buying share right before earnings on | PennyStockPickz | investorshub | 08/05/2015 6:24:09 PM |
Playing the bounce here back to $25. Way | PennyStockPickz | investorshub | 08/05/2015 1:11:36 AM |
Holy shit. This tanked. | PennyStockPickz | investorshub | 08/04/2015 7:35:37 PM |
Aren't insiders shares restricted for two years? | PennyStockPickz | investorshub | 08/03/2015 6:50:53 PM |
sold it at 24 few days ago..insiders bought | mirza3 | investorshub | 08/03/2015 6:33:35 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the...
2024-07-09 22:15:01 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for RPD on July 9, 2024 09:06PM ET. The previous analyst recommendation was Equal-Weight. RPD was trading at $39.72 at issue of the analyst recommendation. The overall analyst consensus : BU...